Maintenance therapy with NA after discontinuation of long-term HBIG therapy is associated with a low risk of HB recurrence after OLT in compliant HB patients.

• 由此我们得出结论：对于依从性好的乙肝病人，在长期的HBIG治疗后持续服用核苷类似物可降低原位肝移植术后乙肝复发风险。